Heron Therapeutics Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Heron Therapeutics Inc 公司

Heron Therapeutics, Inc. 是一家商業階段的生物技術公司。該公司將一系列產品商業化，用於護理急性護理和腫瘤患者。其腫瘤護理產品組合包括 SUSTOL 和 CINVANTI。SUSTOL 用於預防與中度致吐化療 (MEC) 以及蒽環類和環磷酰胺 (AC) 聯合化療方案相關的急性和延遲性惡心和嘔吐。CINVANTI 是阿瑞吡坦的靜脈 (IV) 製劑，阿瑞吡坦是一種 P 物質/神經激肽-1 (NK1) 受體拮抗劑。其急性護理產品組合包括 ZYNRELEF 和 APONVIE。HTX- ZYNRELEF 是一種雙作用局部麻醉劑，可提供局部麻醉劑布比卡因和低劑量非甾體抗炎藥美洛昔康的固定劑量組合。 APONVIE 是一種 NK1 受體拮抗劑的靜脈注射劑型，用於治療術後噁心嘔吐 (PONV)。其產品在美國銷售。

Heron Therapeutics Inc簡介



公司代碼HRTX

公司名稱Heron Therapeutics Inc

上市日期Aug 26, 1987

CEOMr. Craig Alexander Collard

員工數量122

證券類型Ordinary Share

年結日Aug 26

公司地址100 Regency Forest Drive

城市CARY

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編27518

電話18582514400

網址https://www.herontx.com/

公司代碼HRTX

上市日期Aug 26, 1987

CEOMr. Craig Alexander Collard

Heron Therapeutics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Craig Alexander Collard

Chief Executive Officer, Director

504.19K

+10.66%

Ms. Ira Duarte

Chief Financial Officer, Executive Vice President

179.79K

+9.48%

Dr. William P. (Bill) Forbes

Executive Vice President, Chief Development Officer

166.20K

+10.33%

Dr. Sharmila Dissanaike, M.D.

Independent Director

68.45K

-3.44%

Mr. Christian Waage

Independent Director

66.18K

+26.70%

Mr. Craig A. Johnson

Lead Independent Director

65.82K

-5.73%

Mr. Adam Morgan

Chairman of the Board

32.89K

+19.94%

Mr. Michael Kaseta

Independent Director

2.37K

-95.76%

Mr. Mark Hensley

Chief Operating Officer, Executive Vice President

--

Mr. Tom Cusack ,

Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Craig Alexander Collard

Chief Executive Officer, Director

504.19K

+10.66%

Ms. Ira Duarte

Chief Financial Officer, Executive Vice President

179.79K

+9.48%

Dr. William P. (Bill) Forbes

Executive Vice President, Chief Development Officer

166.20K

+10.33%

Dr. Sharmila Dissanaike, M.D.

Independent Director

68.45K

-3.44%

Mr. Christian Waage

Independent Director

66.18K

+26.70%

Mr. Craig A. Johnson

Lead Independent Director

65.82K

-5.73%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

業務USD

名稱

營收

佔比

CINVANTI

24.14M

64.90%

ZYNRELEF

8.19M

22.01%

APONVIE

2.46M

6.62%

SUSTOL

2.40M

6.46%

地區USD

名稱

營收

佔比

United States

37.20M

100.00%

業務

地區

業務USD

名稱

營收

佔比

CINVANTI

24.14M

64.90%

ZYNRELEF

8.19M

22.01%

APONVIE

2.46M

6.62%

SUSTOL

2.40M

6.46%

股東統計

更新時間: 11月1日週六

持股股東

股東類型

持股股東

佔比

Rubric Capital Management LP

16.39%

BlackRock Institutional Trust Company, N.A.

4.98%

The Vanguard Group, Inc.

4.61%

Adage Capital Management, L.P.

4.28%

Velan Capital Investment Management LP

3.81%

其他

65.93%

持股股東

佔比

Rubric Capital Management LP

16.39%

BlackRock Institutional Trust Company, N.A.

4.98%

The Vanguard Group, Inc.

4.61%

Adage Capital Management, L.P.

4.28%

Velan Capital Investment Management LP

3.81%

其他

65.93%

股東類型

持股股東

佔比

Hedge Fund

29.63%

Investment Advisor

23.40%

Investment Advisor/Hedge Fund

15.44%

Research Firm

3.63%

Pension Fund

1.42%

Individual Investor

0.60%

Bank and Trust

0.12%

Insurance Company

0.03%

其他

25.72%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

339

134.06M

76.24%

-19.84M

2025Q2

352

128.42M

84.17%

-20.15M

2025Q1

384

126.94M

83.22%

-22.20M

2024Q4

390

118.52M

78.10%

-45.51M

2024Q3

400

125.21M

82.85%

-42.71M

2024Q2

402

132.96M

88.55%

-36.75M

2024Q1

402

122.65M

81.87%

-45.18M

2023Q4

413

115.58M

77.36%

-37.11M

2023Q3

417

122.12M

87.17%

-25.94M

2023Q2

428

102.54M

85.75%

-39.37M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Rubric Capital Management LP

29.10M

15.87%

+2.39M

+8.94%

Aug 08, 2025

BlackRock Institutional Trust Company, N.A.

9.13M

4.98%

+1.33M

+17.12%

Jun 30, 2025

The Vanguard Group, Inc.

8.47M

4.62%

+245.88K

+2.99%

Jun 30, 2025

Adage Capital Management, L.P.

7.85M

4.28%

--

Jun 30, 2025

Velan Capital Investment Management LP

6.99M

3.81%

--

Jun 30, 2025

Palisade Capital Management, LLC

5.09M

2.77%

-200.03K

-3.78%

Jun 30, 2025

Tejara Capital Ltd.

4.52M

2.46%

-59.99K

-1.31%

Jun 30, 2025

Geode Capital Management, L.L.C.

3.57M

1.95%

+453.08K

+14.55%

Jun 30, 2025

State Street Investment Management (US)

3.46M

1.89%

+208.36K

+6.40%

Jun 30, 2025

D. E. Shaw & Co., L.P.

3.20M

1.75%

+214.10K

+7.17%

Jun 30, 2025

持股ETF



更新時間: 11月2日週日

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.45%

iShares Micro-Cap ETF

0.04%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

Global X Russell 2000 ETF

0.01%

ProShares Hedge Replication ETF

0.01%

iShares Russell 2000 ETF

0.01%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.01%

iShares Russell 2000 Value ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

佔比0.45%

iShares Micro-Cap ETF

佔比0.04%

Invesco RAFI US 1500 Small-Mid ETF

佔比0.01%

Schwab U.S. Small-Cap ETF

佔比0.01%

Global X Russell 2000 ETF

佔比0.01%

ProShares Hedge Replication ETF

佔比0.01%

iShares Russell 2000 ETF

佔比0.01%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.01%

iShares Russell 2000 Value ETF

佔比0.01%

ProShares UltraPro Russell2000

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據